CClinicalTrials.gg
CompletedNCT04979897IMPACCTUpdated Jul 12, 2024Results posted

Impact on Mental, Physical, And Cognitive Functioning of a Critical Care sTay During the COVID-19 Pandemic

An observational study in Covid19, Critical Care and Postintensive Care Syndrome, sponsored by Universidad del Desarrollo. Completed at 7 sites in Chile. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-12.

Sponsored by Universidad del Desarrollo · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
252
Ages
18 Years and older
Sex
All
01

Study summary

Intensive care unit (ICU) survivors and their families frequently present mental, cognitive and physical impairments lasting years. The ongoing pandemic could affect the duration, variety, and severity of these impairments. Our aim is to determine the impact of the COVID-19 pandemic on the physical, mental, and cognitive health of survivors, the experience of their families and their treating healthcare professionals in the long-term.

This is a prospective, multicentre, mixed-methods cohort study in seven Chilean ICUs. The perceptions of family members regarding the ICU stay and the later recovery will be explored 3 months after discharge. Health care professionals will be invited to discuss the challenges faced during the pandemic using semi-structured interviews.

02

Conditions studied

  • Covid19
  • Critical Care
  • Postintensive Care Syndrome

Browse trials for

Keywords

  • Covid19
  • Critical care
  • Postintensive Care Syndrome
  • Rehabilitation
  • Follow-up
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 252 is close to the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Universidad del Desarrollo is the lead sponsor of 23 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adults who were mechanically ventilated in the ICU, either with the diagnosis of COVID-19 or other causes

Inclusion criteria

  • Adult patients (≥18 years old)
  • Mechanically ventilated for at least 48 hours

Exclusion criteria

Exclusion Criteria:

  • Unable to walk independently 2 weeks prior to ICU admission (with or without a gait aid)
  • S5q \< 5 or CAM-ICU positive within 72 hours after ICU discharge
  • Patient who do not understand or speak Spanish
  • Patient unable to communicate verbally
  • Burn or severe trauma as admission diagnosis
  • Any neurological disorder (i.e. spinal cord injury, stroke and brain tumours) as admission diagnosis
  • Transferred to a non-participating study centre before ICU discharge assessment
  • Recent prolonged hospital stay (extended by more than 3 months)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
252 participants (actual)
Patient registry
No

Groups and cohorts

  • Intensive care unit stay during high bed occupancy in the COVID-19 pandemic

    Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a high bed occupancy in the pandemic

    Other: Intensive care unit stay during the COVID-19 pandemic

  • Intensive care unit stay during low bed occupancy in the COVID-19 pandemic

    Adult patients (≥18 years old) who are mechanically ventilated for at least 48 hours in one of the participating ICUs during a low bed occupancy in the pandemic

    Other: Intensive care unit stay during the COVID-19 pandemic

Interventions

  • OtherIntensive care unit stay during the COVID-19 pandemic

    Patients will be screened daily for a potential ICU discharge. Each site coordinator, which is a clinician physiotherapist responsible for the site, will check that the patient is delirium-free (CAM-ICU negative) and cooperative (i.e. using 5 standardised questions: open \[close\] your eyes; look at me; open your mouth and stick out your tongue; nod your head; raise your eyebrows when I have counted up to five) within 72 hours from ICU discharge. Every patient deemed eligible will be invited to participate through a face-to-face visit by the assigned evaluator, receiving verbal and written information about the study

06

What researchers measure

Primary outcomes

  1. World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

    The WHODAS 2.0 is a self-reported disability questionnaire based on the International Classification of Functioning, Disability, and Health (ICF). It includes 36 questions, organised under six domains (cognition, mobility, self-care, getting along, life activities and participation). Each question must be answered based on the perceived difficulty for performing activities using a 5-point scale (none, mild, moderate, severe and extreme). The overall score of each domain, it is transformed into a score between 0 and 100, where 0 means no disability and 100 is complete disability

    Time frame: 6 months after the ICU discharge

Secondary outcomes

  1. Clinical Frailty Scale

    The CFS evaluates specific domains including physical functioning, activities of daily living (ADL), instrumental ADL, assistance for personal care, comorbidities, and cognition to generate a frailty score using a 9-point scale ranging from 1 (very fit) to 9 (terminally ill). A score greater than 4 is considered fragile

    Time frame: Within 72 hours from ICU discharge

  2. Medical Research Council Sum Score (MRC-SS): Peripheral Muscle Strength

    the MRC-SS consists of a standardised examination of six muscle groups bilaterally (i.e. shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension and dorsiflexion). All muscle groups are scored using a 6-point scale between 0 and 5 (0 = no visible /palpable contraction; 1 = visible / palpable contraction or no limb movement; 2 = limb movement, but not against gravity; 3 = movement against the gravity over nearly the entire range of motion; 4 = motion against gravity and resistance, subjectively adjusted for gender and age; 5 = normal force). The score goes from 0 (no strength) to a maximum score of 60 points, indicating normal peripheral strength.

    Time frame: Within 72 hours from ICU discharge

  3. Functional Status Score for the Intensive Care Unit (FSS-ICU)

    The FSS-ICU is a mobility instrument to score the level of physical assistance required when performing five functional activities: rolling, transfer from supine to sit, sitting at the edge of the bed, transfer from sitting to stand, and walking. Each activity is scored using a 7-point scale ranging from 0 (not able to perform) to 7 (complete independence). The resulting overall score ranges from 0 to 35 points, where a higher scores indicates better performance.

    Time frame: Within 72 hours from ICU discharge

  4. Montreal Cognitive Assessment-Blind (MoCA Blind)

    The MoCA blind is a cognitive screening tool designed to detect cognitive dysfunction in five areas: memory, attention, language, abstraction and orientation. Each domain is scored separately for a total score ranging from 0 to 22 points. A score equal to or greater than 18 points is considered normal cognition.

    Time frame: 6 months after the ICU discharge

  5. Hospital Anxiety and Depression Scale (HADS)

    The HADS is an interviewer or self-administered questionnaire designed to identify anxiety and depressive symptoms in a wide variety of in-hospital patients, which requires between 2 and 5 minutes to be completed. The HADS has fourteen questions, seven for anxiety and seven for depressive symptoms. Each question is rated with a 4-point scale ranging from 0 ("absence") to 3 ("extreme presence"), resulting in a sum score of 21 points per subscale. For each subscale, a score \>8 indicates suspected anxiety or depression, while a score \>11 indicates clinical symptoms of anxiety or depression.

    Time frame: 6 months after the ICU discharge

  6. Impact of Events Scale-Revised (IES-R)

    The IES-R is an interviewer or self-administered questionnaire designed to measure the subjective distress caused by traumatic events that has been validated for critical illness survivors. It comprises 22 questions in three subscales: intrusion, avoidance, and hyperarousal. Questions are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The score goes from 0 to 88 points. Scores above 33 are indicative of post-traumatic stress symptoms.

    Time frame: 6 months after the ICU discharge

  7. European Quality of Life Health Questionnaire (EQ-5D-3L)

    The EQ-5D-3L is an interviewer or self-administered questionnaire of health status or health-related quality of life, including five domains: mobility, self-care, usual activities, pain/discomfort, anxiety/depression and global health state. Each domain is scored based on 3 levels of severity: no problems, some problems, and extreme problems. Each combination of answers can be translated into a utility score, where 0 is similar to being dead and 1 represents the best possible quality of life. The utility scores were obtained using the Chilean Social valuation of EQ-5D health states (DOI: http://dx.doi.org/10.1016/j.jval.2011.09.002)

    Time frame: 6 months after the ICU discharge

  8. Employment Status

    The employment status was evaluated using the following questions: What is your current employment status? What working hours do you have? and has your employment situation changed after your ICU stay?

    Time frame: 6 months after the ICU discharge

  9. Survival

    Number of patients who survived

    Time frame: 6 months after the ICU discharge

Other outcomes

  1. Cohort Retention Rate

    Number of patients who can be contacted and evaluated

    Time frame: Every month during one year

07

Results

Posted Jul 12, 2024

Participant flow

October 20th, 2020 to April 12th, 2021

Participant flow — Overall Study
MilestoneIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Started149103
3-month follow-up5550
Completed3037
Not completed11966
Withdrew: Death18
Withdrew: Lost to follow-up11156
Withdrew: Withdrawal by subject72

Outcome measures

PrimaryWorld Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)

The WHODAS 2.0 is a self-reported disability questionnaire based on the International Classification of Functioning, Disability, and Health (ICF). It includes 36 questions, organised under six domains (cognition, mobility, self-care, getting along, life activities and participation). Each question must be answered based on the perceived difficulty for performing activities using a 5-point scale (none, mild, moderate, severe and extreme). The overall score of each domain, it is transformed into a score between 0 and 100, where 0 means no disability and 100 is complete disability

Time frame:
6 months after the ICU discharge
Reported as:
Median · units on a scale
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
units on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)5 (2 to 18)13.5 (2 to 23)
SecondaryClinical Frailty Scale

The CFS evaluates specific domains including physical functioning, activities of daily living (ADL), instrumental ADL, assistance for personal care, comorbidities, and cognition to generate a frailty score using a 9-point scale ranging from 1 (very fit) to 9 (terminally ill). A score greater than 4 is considered fragile

Time frame:
Within 72 hours from ICU discharge
Reported as:
Median · score on a scale
Clinical Frailty Scale
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Clinical Frailty Scale2 (2 to 3)3 (2 to 3)
SecondaryMedical Research Council Sum Score (MRC-SS): Peripheral Muscle Strength

the MRC-SS consists of a standardised examination of six muscle groups bilaterally (i.e. shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension and dorsiflexion). All muscle groups are scored using a 6-point scale between 0 and 5 (0 = no visible /palpable contraction; 1 = visible / palpable contraction or no limb movement; 2 = limb movement, but not against gravity; 3 = movement against the gravity over nearly the entire range of motion; 4 = motion against gravity and resistance, subjectively adjusted for gender and age; 5 = normal force). The score goes from 0 (no strength) to a maximum score of 60 points, indicating normal peripheral strength.

Time frame:
Within 72 hours from ICU discharge
Reported as:
Median · score on a scale
Medical Research Council Sum Score (MRC-SS): Peripheral Muscle Strength
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Medical Research Council Sum Score (MRC-SS): Peripheral Muscle Strength52 (46 to 57)50 (44 to 57)
SecondaryFunctional Status Score for the Intensive Care Unit (FSS-ICU)

The FSS-ICU is a mobility instrument to score the level of physical assistance required when performing five functional activities: rolling, transfer from supine to sit, sitting at the edge of the bed, transfer from sitting to stand, and walking. Each activity is scored using a 7-point scale ranging from 0 (not able to perform) to 7 (complete independence). The resulting overall score ranges from 0 to 35 points, where a higher scores indicates better performance.

Time frame:
Within 72 hours from ICU discharge
Reported as:
Median · score on a scale
Functional Status Score for the Intensive Care Unit (FSS-ICU)
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Functional Status Score for the Intensive Care Unit (FSS-ICU)26 (21 to 32)27 (19 to 32)
SecondaryMontreal Cognitive Assessment-Blind (MoCA Blind)

The MoCA blind is a cognitive screening tool designed to detect cognitive dysfunction in five areas: memory, attention, language, abstraction and orientation. Each domain is scored separately for a total score ranging from 0 to 22 points. A score equal to or greater than 18 points is considered normal cognition.

Time frame:
6 months after the ICU discharge
Reported as:
Median · score on a scale
Montreal Cognitive Assessment-Blind (MoCA Blind)
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Montreal Cognitive Assessment-Blind (MoCA Blind)21 (19 to 22)20 (18 to 22)
SecondaryHospital Anxiety and Depression Scale (HADS)

The HADS is an interviewer or self-administered questionnaire designed to identify anxiety and depressive symptoms in a wide variety of in-hospital patients, which requires between 2 and 5 minutes to be completed. The HADS has fourteen questions, seven for anxiety and seven for depressive symptoms. Each question is rated with a 4-point scale ranging from 0 ("absence") to 3 ("extreme presence"), resulting in a sum score of 21 points per subscale. For each subscale, a score \>8 indicates suspected anxiety or depression, while a score \>11 indicates clinical symptoms of anxiety or depression.

Time frame:
6 months after the ICU discharge
Reported as:
Median · score on a scale
Hospital Anxiety and Depression Scale (HADS)
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Depression subscale7 (5 to 8)7 (5 to 9)
Anxiety subscale6 (3 to 9)7 (3 to 10)
SecondaryImpact of Events Scale-Revised (IES-R)

The IES-R is an interviewer or self-administered questionnaire designed to measure the subjective distress caused by traumatic events that has been validated for critical illness survivors. It comprises 22 questions in three subscales: intrusion, avoidance, and hyperarousal. Questions are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The score goes from 0 to 88 points. Scores above 33 are indicative of post-traumatic stress symptoms.

Time frame:
6 months after the ICU discharge
Reported as:
Median · score on a scale
Impact of Events Scale-Revised (IES-R)
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Impact of Events Scale-Revised (IES-R)13.5 (5 to 38)22 (7 to 44)
SecondaryEuropean Quality of Life Health Questionnaire (EQ-5D-3L)

The EQ-5D-3L is an interviewer or self-administered questionnaire of health status or health-related quality of life, including five domains: mobility, self-care, usual activities, pain/discomfort, anxiety/depression and global health state. Each domain is scored based on 3 levels of severity: no problems, some problems, and extreme problems. Each combination of answers can be translated into a utility score, where 0 is similar to being dead and 1 represents the best possible quality of life. The utility scores were obtained using the Chilean Social valuation of EQ-5D health states (DOI: http://dx.doi.org/10.1016/j.jval.2011.09.002)

Time frame:
6 months after the ICU discharge
Reported as:
Median · score on a scale
European Quality of Life Health Questionnaire (EQ-5D-3L)
score on a scaleIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
European Quality of Life Health Questionnaire (EQ-5D-3L)0.79 (0.57 to 1.00)0.74 (0.51 to 0.79)
SecondaryEmployment Status

The employment status was evaluated using the following questions: What is your current employment status? What working hours do you have? and has your employment situation changed after your ICU stay?

Time frame:
6 months after the ICU discharge
Reported as:
Count of participants · Participants
Employment Status
ParticipantsIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Employed-Full time1817
Employed-Part time33
Umemployed49
Retired48
No answer10
SecondarySurvival

Number of patients who survived

Time frame:
6 months after the ICU discharge
Reported as:
Count of participants · Participants
Survival
ParticipantsIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Survival14895
Other pre-specifiedCohort Retention Rate

Number of patients who can be contacted and evaluated

Time frame:
Every month during one year
Reported as:
Count of participants · Participants
Cohort Retention Rate
ParticipantsIntensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic
Cohort Retention Rate3037

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intensive Care Unit Stay During High Bed Occupancy in the COVID-19 Pandemic1/149 (0.7%)0/149 (0%)0/149 (0%)
Intensive Care Unit Stay During Low Bed Occupancy in the COVID-19 Pandemic8/103 (7.8%)0/103 (0%)0/103 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 PandemicTotal
Median55 (44 to 63)61 (51 to 71)57 (47 to 67)
Sex: Female, Male
Sex: Female, Male(Participants)Intensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 PandemicTotal
Female484189
Male10162163
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Intensive Care Unit Stay During High Bed Occupancy in the COVID-19 PandemicIntensive Care Unit Stay During Low Bed Occupancy in the COVID-19 PandemicTotal
Count of participants——0
08

Study locations

7 sites
  • Hospital Regional Dr. Leonardo Guzmán de Antofagasta
    Antofagasta, Chile
  • Hospital San Pablo de Coquimbo
    Coquimbo, Chile
  • Clínica Alemana de Santiago
    Santiago, Chile
  • Clínica BUPA
    Santiago, Chile
  • Clínica INDISA
    Santiago, Chile
  • Hospital del Salvador
    Santiago, Chile
  • Hospital Metropolitano
    Santiago, Chile
09

References and documents

Publications

  • Castro-Avila AC, Merino-Osorio C, Gonzalez-Seguel F, Camus-Molina A, Leppe J; IMPACCT COVID-19 study group. Impact on Mental, Physical and Cognitive functioning of a Critical care sTay during the COVID-19 pandemic (IMPACCT COVID-19): protocol for a prospective, multicentre, mixed-methods cohort study. BMJ Open. 2021 Sep 8;11(9):e053610. doi: 10.1136/bmjopen-2021-053610. PubMed 34497087 ↗

Study documents

  • Protocol and statistical analysis plan · May 18, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04979897
Lead sponsor
Universidad del Desarrollo
Collaborators
Clinica Alemana de Santiago, Clinica Indisa, Clinica Bupa Santiago, Hospital del Salvador, Hospital Clínico Regional De Antofagasta Dr Leonardo Guzman, Hospital San Pablo de Coquimbo, Hospital Metropolitano
Responsible party
Ana Cristina Castro (Visiting lecturer, Universidad del Desarrollo) — Principal investigator
First posted
Jul 28, 2021
Start date
Oct 20, 2020
Primary completion
Nov 2, 2021
Completion
Sep 2, 2022
Results posted
Jul 12, 2024
Last update
Jul 12, 2024

Study contacts

Ana Castro-Ávila, PhD
principal investigator · Universidad del Desarrollo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion